Rediscovering citrate as a biomarker for prostate cancer

IF 12.1 1区医学 Q1 UROLOGY & NEPHROLOGY Nature Reviews Urology Pub Date : 2024-05-29 DOI:10.1038/s41585-024-00899-3

Lucas Galey, Ayokunle Olanrewaju, Hermann Nabi, Jean-Sébastien Paquette, Frédéric Pouliot, Étienne Audet-Walsh

引用次数: 0

Abstract

For many years, PSA has been the most commonly used biomarker for prostate cancer screening and diagnosis. Although serum PSA measurement is highly sensitive, this biomarker has several limitations. Citrate, a molecule closely linked to the unique metabolism of prostate cancer, has the potential to be used as a complementary biomarker alongside PSA.

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

重新发现作为前列腺癌生物标志物的柠檬酸盐。

多年来，前列腺特异性抗原（PSA）一直是筛查和诊断前列腺癌最常用的生物标志物。虽然血清 PSA 测量灵敏度很高，但这种生物标志物存在一些局限性。柠檬酸盐是一种与前列腺癌独特的新陈代谢密切相关的分子，有可能与 PSA 一起用作补充性生物标志物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Nature Reviews Urology 医学-泌尿学与肾脏学

CiteScore

12.50

自引率

2.60%

发文量

123

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Urology is part of the Nature Reviews portfolio of journals.Nature Reviews' basic, translational and clinical content is written by internationally renowned basic and clinical academics and researchers. This journal targeted readers in the biological and medical sciences, from the postgraduate level upwards, aiming to be accessible to professionals in any biological or medical discipline. The journal features authoritative In-depth Reviews providing up-to-date information on topics within a field's history and development. Perspectives, News & Views articles, and the Research Highlights section offer topical discussions and opinions, filtering primary research from various medical journals. Covering a wide range of subjects, including andrology, urologic oncology, and imaging, Nature Reviews provides valuable insights for practitioners, researchers, and academics within urology and related fields.

期刊最新文献

Tomorrow’s patient management: LLMs empowered by external tools Metastasis development in non-muscle-invasive bladder cancer HSD3B1, prostate cancer mortality and modifiable outcomes Disruption of circadian rhythm as a potential pathogenesis of nocturia. Molecular imaging of renal cell carcinomas: ready for prime time.